Is it a good time to invest in the UK?
Temple Bar Investment Trust is a diversified bet on British equities and looks excellent value, says Max King

Since they took over the management of the Temple Bar Investment Trust (LSE: TMPL) in October 2020, Ian Lance and Nick Purves have generated a total return of 100% compared with 55% for the FTSE All-Share index.
This is also well ahead of global indices. When the board moved the management contract, they chose to continue the previous manager’s value strategy rather than join the then-fashionable pursuit of growth.
This has proved shrewd, not just because the UK market, in which Temple Bar is focused, is short of growth stocks, but also because the trust’s contrarian reputation was worth preserving. “We are very much contrarians,” says Lance.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Although the global pendulum has hardly swung back to value investing, the UK has proved a fertile hunting ground for recovery stocks.
In the face of indifference, if not animosity, towards quoted companies by government, regulators and the general public, corporate managements have been shaken out of their torpor and complacency into improving investors’ returns.
Think twice before investing in collapsed companies
Lance and Purves avoid “value traps” (companies that are cheap, but show no signs of improvement) and “mindless contrarianism” – buying into companies solely on the basis of a collapse in their share prices.
“Investors love to buy what everyone else hates, but having respect for what the market is saying is key. Don’t buy rubbish.” They emphasise the importance of discipline in value investing as it is “tricky – people are hardwired to conform”.
Also, “bargains are rare, so make the most of them” and “timing is never easy, so be patient, be long-term”. In 2023, they missed the FTSE 100’s top performer, Rolls-Royce, which tripled and has since risen by another 40%, but were invested in Marks & Spencer, which more than doubled.
It is in the top-ten holdings at just 4% of the portfolio as they have taken profits. This may prove premature; contrarian investors are prone to selling too early, at the stage when recovery is turning into growth.
On the other hand, Centrica, another top performer in 2023, has declined by 25% from its 2023 peak, but “it’s still very cheap on a multiple of four times earnings with half its market value in cash”, according to Lance.
The impressive performance of International Distributions Services, held since 2020, was the result of favourable year-end pricing rather than any sustained uptrend, so it looks as though even more patience will be needed.
“It has £10bn of loss-making revenue in Royal Mail, including 50% of the UK parcels market,” says Lance. The trust’s worst performer of 2023 was Anglo American.
Energy stocks strengthen
Three of the top four holdings (BP, Shell and Total), comprising 19% of the portfolio, are energy majors. They were held before the change of management, but added to in the pandemic “when the oil price briefly went negative”.
Their good performance since then will surely be enhanced by their “de-emphasising” of renewable energy in favour of their core oil and gas business. Total is part of the 30% of the portfolio listed outside the UK.
This also includes Dutch insurance group NN (“a decent well-run business that was very cheap”) and car company Stellantis (“bought on an earnings multiple of two and a dividend yield of 9%; 30% of its market value is in cash”).
UK banking stocks
Financials comprise 27% of the portfolio, more than half of which is accounted for by three FTSE-100 lame ducks: NatWest (formerly RBS), Aviva and Barclays.
Branch closures are eroding the competitive advantage that incumbent banks have over start-ups, while more stringent capital adequacy rules limit their return on capital.
Banks have retreated from corporate lending and now focus on mortgages, which the government’s Help to Buy programme has made highly competitive. In addition, every time the Financial Conduct Authority (the City regulator) needs to top up its bonus pool, it seems it looks for an excuse to raid the UK banks.
“Hundreds of companies have come together to make Aviva,” boasts its website, which just shows that Aviva’s history is one of merging and shrinking.
As a pension-fund manager it was at the forefront of the charge out of UK equities and into government bonds – which have made no real Temple Bar Investment Trust is a diversified bet on British equities and looks excellent value A top tip for a UK turnaround returns over the past 20 years.
Nevertheless, the share prices of all banks appear to have turned the corner. This often signals better times ahead for companies in the doghouse, and managements appear to have the bit between their teeth.
With price to book value ratios of 0.4 for Barclays and 0.6 for NatWest, investors are not expecting either to generate much in the way of return on capital. Lance points out that NatWest has returned 43% of its market value to shareholders in dividends and share buybacks in the last two years.
While Barclays has returned only 21%, it has generated 47% of its market value in earnings in the last two years, compared with 39% for NatWest.
Discounted shares
But if it was easy to see the optimistic case for these (and other) shares, they wouldn’t be this cheap. Temple Bar’s shares trade at a 10% discount to net asset value (NAV) and yield 4%, last year’s dividend having been increased by 2.7%.
The trust is as good a bet as you’ll get on a UK market turnaround, with the spread of investments taking away the risk of being left behind in one of those value traps. As Lance says, “if you are a good investor and pick the right stocks, you can still make money in the UK”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Max has an Economics degree from the University of Cambridge and is a chartered accountant. He worked at Investec Asset Management for 12 years, managing multi-asset funds investing in internally and externally managed funds, including investment trusts. This included a fund of investment trusts which grew to £120m+. Max has managed ten investment trusts (winning many awards) and sat on the boards of three trusts – two directorships are still active.
After 39 years in financial services, including 30 as a professional fund manager, Max took semi-retirement in 2017. Max has been a MoneyWeek columnist since 2016 writing about investment funds and more generally on markets online, plus occasional opinion pieces. He also writes for the Investment Trust Handbook each year and has contributed to The Daily Telegraph and other publications. See here for details of current investments held by Max.
-
When is the “Bed & ISA” deadline? Cut-off dates for major investment platforms
The “Bed & ISA” deadline varies from provider to provider. We share a round-up of the key dates across major investment platforms
By Katie Williams Published
-
Spring Statement: what could Rachel Reeves say about pensions?
The chancellor will deliver her Spring Statement on 26 March. We look at whether there will be any announcements on pensions that could affect savers or retirees
By Ruth Emery Published
-
Why CEOs deserve a pay rise
Opinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
By Stuart Watkins Published
-
Rolls-Royce stock jumps 15% – could it climb further?
Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
By Dr Matthew Partridge Published
-
The power of private markets
Interview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
By Andrew Van Sickle Published
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success
By Dr Mike Tubbs Published
-
Global investors have overlooked these top tips in emerging markets
Opinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
By Chris Tennant Published
-
King Coal has not been dethroned yet — should you buy?
The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
By Rupert Hargreaves Published
-
It’s time to start buying Europe again, says Merryn Somerset Webb
Opinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
By Merryn Somerset Webb Published
-
Prosus to buy Just Eat for €4.1 billion as takeaway boom fades
Food-delivery platform Just Eat has been gobbled up by a Dutch rival. Now there could be further consolidation in the sector
By Dr Matthew Partridge Published